ANGONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends May 31
ANGIODYNAMICS INC
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 8, 2026
$11.39+0.15 (+1.33%)
Close on Oct 19, 2026
- Market cap
- $478.63M
- P/E (TTM)
- –
- Dividend yield
- –
Angiodynamics statistics
Financials through Aug 31, 2026, price as of Oct 19, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison
Valuation
| Measure | Angiodynamics | Industry median |
|---|---|---|
| Market Cap | $479.00M | $230.55M |
| Enterprise Value | $445.03M | $202.97M |
| PS Ratio | 1.47 | 3.10 |
| PB Ratio | 2.92 | 3.04 |
| P/TBV Ratio | 4.69 | 4.43 |
| P/FCF Ratio | 331.72 | 27.30 |
| P/OCF Ratio | 130.41 | 22.47 |
Enterprise value
| Measure | Angiodynamics | Industry median |
|---|---|---|
| EV / Sales | 1.37 | 2.91 |
| EV / FCF | 308.19 | 27.89 |
Income (trailing twelve months)
| Measure | Angiodynamics | Industry median |
|---|---|---|
| Revenue | $325.38M | $102.39M |
| Gross Profit | $181.08M | $60.36M |
| Operating Income | -$36.57M | -$4.31M |
| Pretax Income | -$32.76M | -$2.37M |
| Net Income | -$32.94M | -$6.57M |
| EBITDA | -$14.07M | -$1.98M |
| EPS (Diluted) | -$0.78 | -$0.08 |
Margins
| Measure | Angiodynamics | Industry median |
|---|---|---|
| Gross Margin | 55.7% | 55.2% |
| Operating Margin | -11.2% | -6.04% |
| Pretax Margin | -10.1% | -4.11% |
| Profit Margin | -10.1% | -10.5% |
| EBITDA Margin | -4.32% | -2.67% |
| FCF Margin | 0.44% | 0.02% |
Returns
| Measure | Angiodynamics | Industry median |
|---|---|---|
| Return on Equity (ROE) | -19.2% | -18.2% |
| Return on Assets (ROA) | -13.0% | -13.3% |
| Return on Invested Capital (ROIC) | -21.4% | -3.69% |
| Return on Capital Employed (ROCE) | -20.1% | -9.07% |
Growth
| Measure | Angiodynamics | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 8.20% | 8.85% |
| Revenue Growth (3Y CAGR) | -1.86% | 7.08% |
| Revenue Growth (5Y CAGR) | 1.93% | 11.8% |
Balance sheet
| Measure | Angiodynamics | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $33.97M | $36.66M |
| Net Cash (Debt) | $33.97M | $3.92M |
| Net Cash Per Share | $0.81 | $0.28 |
| Equity (Book Value) | $163.96M | $55.33M |
| Book Value Per Share | $3.90 | $2.87 |
| Tangible Book Value | $102.07M | $10.79M |
| Working Capital | $83.31M | $56.72M |
Financial position
| Measure | Angiodynamics | Industry median |
|---|---|---|
| Current Ratio | 2.40 | 2.48 |
| Quick Ratio | 1.32 | 1.53 |
Cash flow (trailing twelve months)
| Measure | Angiodynamics | Industry median |
|---|---|---|
| Operating Cash Flow | $3.67M | -$566.22K |
| Capital Expenditures | -$2.23M | -$3.69M |
| Free Cash Flow | $1.44M | -$696.00K |
| FCF Per Share | $0.03 | -$0.02 |
Efficiency
| Measure | Angiodynamics | Industry median |
|---|---|---|
| Asset Turnover | 1.28 | 0.58 |
| Inventory Turnover | 2.46 | 2.21 |
| Revenue Per Employee | $514.84K | $322.92K |
| Profits Per Employee | -$52.11K | -$51.88K |
| Employee Count | 632 | 185 |
Dividends and yields
| Measure | Angiodynamics | Industry median |
|---|---|---|
| Earnings Yield | -6.88% | -6.88% |
| FCF Yield | 0.30% | -0.45% |
Shares
| Measure | Angiodynamics | Industry median |
|---|---|---|
| Shares Outstanding | 42,054,500 | 44,302,700 |
| Shares Change (YoY) | 1.79% | 3.36% |
| Shares Change (QoQ) | 1.74% | 0.27% |
| Float | 39,675,000 | 37,462,700 |
| Shares Held by Insiders | 5.66% | 10.5% |
| Shares Held by Institutions | 91.0% | 63.5% |
Taxes
| Measure | Angiodynamics | Industry median |
|---|---|---|
| Income Tax | $178.00K | $1.52M |
Scores
| Measure | Angiodynamics | Industry median |
|---|---|---|
| Altman Z-Score | 2.21 | 1.95 |
| Piotroski F-Score | 5 | 5 |
| Beneish M-Score | -3.08 | -2.64 |
Calculated by StockData from Angiodynamics's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.